These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36060957)

  • 21. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
    Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
    Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.
    Yu C; Gong AY; Chen D; Solelo Leon D; Young CY; Chen XM
    Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coactivator selective regulation of androgen receptor activity.
    Agoulnik IU; Weigel NL
    Steroids; 2009 Aug; 74(8):669-74. PubMed ID: 19463689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer.
    Tan KN; Avery VM; Carrasco-Pozo C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.
    Jaganathan A; Chaurasia P; Xiao GQ; Philizaire M; Lv X; Yao S; Burnstein KL; Liu DP; Levine AC; Mujtaba S
    Mol Endocrinol; 2014 Jun; 28(6):872-85. PubMed ID: 24702180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor interacts with a novel MYST protein, HBO1.
    Sharma M; Zarnegar M; Li X; Lim B; Sun Z
    J Biol Chem; 2000 Nov; 275(45):35200-8. PubMed ID: 10930412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
    Choi KC; Park S; Lim BJ; Seong AR; Lee YH; Shiota M; Yokomizo A; Naito S; Na Y; Yoon HG
    Biochem J; 2011 Jan; 433(1):235-44. PubMed ID: 20955177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis.
    DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W
    Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-4 activates androgen receptor through CBP/p300.
    Lee SO; Chun JY; Nadiminty N; Lou W; Feng S; Gao AC
    Prostate; 2009 Feb; 69(2):126-32. PubMed ID: 18819102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
    Culig Z
    J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-histone protein acetylation by the evolutionarily conserved GCN5 and PCAF acetyltransferases.
    Downey M
    Biochim Biophys Acta Gene Regul Mech; 2021 Feb; 1864(2):194608. PubMed ID: 32711095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttranslational modification of the androgen receptor in prostate cancer.
    van der Steen T; Tindall DJ; Huang H
    Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants.
    Korkmaz CG; Frønsdal K; Zhang Y; Lorenzo PI; Saatcioglu F
    J Endocrinol; 2004 Sep; 182(3):377-89. PubMed ID: 15350180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.
    Wiesel-Motiuk N; Assaraf YG
    Drug Resist Updat; 2020 Dec; 53():100729. PubMed ID: 33130515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KATs off: Biomedical insights from lysine acetyltransferase inhibitors.
    Whedon SD; Cole PA
    Curr Opin Chem Biol; 2023 Feb; 72():102255. PubMed ID: 36584580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.
    Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y
    Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
    Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
    Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.